Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)

In vitro tests Fourteen months after the drug reaction, in vitro tests to identify the causal agent were performed. The lymphocyte transformation test (LTT) showed a marked proliferation to ceftazidime (stimulation index (SI): 17 at 100mcg/mL). CD25 was upregulated on CD4+ (induced expression: 17%) and CD8+ (induced expression: 8%) T cells as shown by flow cytometry when cultured with ceftazidi...

DRESS Syndrome: Drug Reaction With Eosinophilia and Systemic Symptoms.

DRESS syndrome is a cutaneous and systemic drug reaction with severe complications and a long course that can be fatal. Recognition may be difficult, and the condition is just rare enough that clinicians will eventually see it but may not be familiar with it. This review will focus on key elements to help clinicians with the challenges of recognition and differential diagnosis.

Killing with kindness? Drug reaction eosinophilia with systemic symptoms (DRESS) masquerading as acute severe sepsis.

Phenytoin-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A case report.

BACKGROUND Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is an uncommon but serious hypersensitivity drug reaction most frequently associated with antiepileptics. Clinical manifestations include rash, fever, and visceral organ involvement, most commonly hepatitis. The mortality rate associated with DRESS syndrome is approximately 10%, the majority due to fulminant liver fai...

Bosentan-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.